research glp 1 Penn researchers say inconsistent GLP1 use could reduce effectiveness of weight loss GLP-1 Receptor Agonist Market Size

doi: 10.1111/dom.14725 45 CrinAGrugniG

Remove the needle and dispose of it: After the injection, carefully remove the needle by pulling it out in the same direction it was inserted

health insurance landscape creates both the opportunity and the constraint: commercial insurance covering GLP-1 for diabetes generates large, well-reimbursed prescription volumes, but coverage for obesity indications varies widely, with Medicare explicitly prohibited from covering weight loss drugs until the Treat and Reduce Obesity Act passes a legislative gap that excludes tens of millions of Medicare beneficiaries from covered GLP-1 obesity access

16+ weeks: Long-term weight loss trends emerge